As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics.

Building on the success of last year’s meeting, the 3^rd Neuroimmunology Drug Development Summit will uncover how leading companies in this emerging field are discovering immune-modulating targets and deploying immuno-neurology across clinical case studies. As we gather the best minds in this infant field we will put a spotlight on the latest key learnings across microglia, astrocytes, STING, TREM2 and more to help pave the way to translating key technological and mechanistic insights towards the clinic.

Join this intimate, industry led forum to not only learn from those pioneering the field, but to network and build meaningful partnerships with 80+ neuroimmunology drug development experts.

To find out more and view the 2021 speaker line-up, download the 2021 event guide.